4
Changes in Ownership
enGene Therapeutics Inc. Filed Acc 0000929638-24-001069
Chief Technology Officer acquired 52,940 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CHEUNG ANTHONY TZEYEW · Chief Technology Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-18 | Exercise or conversion : show line 1 in the form | +52,940 | $0.89 | $47,117 | 102,873 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-18 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −52,940 | 0 | D |
Loading xslF345X05/form4.xml…